<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace コレクション: 2017-06</title>
  <link rel="alternate" href="http://hdl.handle.net/10564/3412" />
  <subtitle>2017-06</subtitle>
  <id>http://hdl.handle.net/10564/3412</id>
  <updated>2026-04-10T15:40:44Z</updated>
  <dc:date>2026-04-10T15:40:44Z</dc:date>
  <entry>
    <title>特発性上腰ヘルニアの1例　本邦58例の検討</title>
    <link rel="alternate" href="http://hdl.handle.net/10564/3417" />
    <author>
      <name>中辻, 直之</name>
    </author>
    <author>
      <name>八倉, 一晃</name>
    </author>
    <author>
      <name>越智, 祥隆</name>
    </author>
    <id>http://hdl.handle.net/10564/3417</id>
    <updated>2018-02-15T07:06:51Z</updated>
    <published>2017-06-29T15:00:00Z</published>
    <summary type="text">タイトル: 特発性上腰ヘルニアの1例　本邦58例の検討
著者: 中辻, 直之; 八倉, 一晃; 越智, 祥隆
抄録: The superior lumbar triangle is an anatomically weak space in the lumbar area. A&#xD;
superior lumbar hernia rarely occurs in this triangle. In this paper, a case of idiopathic superior&#xD;
lumbar hernia is reported with some reviews of previous literature. A 78-year-old man visited&#xD;
us because of a mass and pain in the right lumbar area. Physical examination revealed a 9x9cm,&#xD;
soft and smooth-surfaced mass. Computed tomography (CT) showed a defect in the right dorsal&#xD;
abdominal wall and a prolapse of the retroperitoneal fat tissue through the defect. Diagnosis of&#xD;
an idiopathic right superior lumbar hernia was established, and hernioplasty was performed&#xD;
At operation, a hernial orifice measuring 2cm in diameter was found in the aponeurosis of the&#xD;
transversus abdominis, and fat tissue prolapsed through this orifice. The aponeurosis was closed&#xD;
by several interrupted sutures and an onlay patch (Bard Mesh®) was fixed on the superior&#xD;
lumbar triangle.
内容記述: 個人の特定が出来ると思われる記述が掲載されているため本文PDFの登録はなし</summary>
    <dc:date>2017-06-29T15:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Effects of Reminiscence Therapy Using Nostalgic SONGS on The Cognitive Function of The Elderly Living in The Community.</title>
    <link rel="alternate" href="http://hdl.handle.net/10564/3416" />
    <author>
      <name>Okuda, Jun</name>
    </author>
    <author>
      <name>Hashimoto, Akiko</name>
    </author>
    <author>
      <name>Jikumaru, Kiyoko</name>
    </author>
    <id>http://hdl.handle.net/10564/3416</id>
    <updated>2019-02-06T05:10:13Z</updated>
    <published>2017-06-29T15:00:00Z</published>
    <summary type="text">タイトル: Effects of Reminiscence Therapy Using Nostalgic SONGS on The Cognitive Function of The Elderly Living in The Community.
著者: Okuda, Jun; Hashimoto, Akiko; Jikumaru, Kiyoko
抄録: The study aimed to examine the effects of reminiscence therapy using nostalgic songs on the cognitive function of elderly people living in the community. The subjects were 34 people who had undergonea ssessment of their vital functions using a basic check list and stated that they had problems related to "withdrawal" or "cognitive functions". Their cognitive functions were assessed using the Hasegawa Dementia Scale-Revised (HDS-R) and Mini-Mental State Examination (MMSE) prior to and following the implementation of reminiscence intervention using nostalgic songs. The cognitive functions of the elderly were classified into three levels and assessed according to the judgment criteria of those scales. There were significant differences in the total HDS-R score and scores for the subscale items -"recital of numbers in reverse order" and "delayed recall"-received by all subjects. There were also significant differences in the total MMSE score and scores for the subscale items -"spatial orientation" and "delayed recall" -received by all subjects. Regarding cognitive function levels, there were significant differences in the total score and subscale score for "delayed recal" received by elderly people who had been determined as having "cognitive dysfunction" using the HDS-R and "mild cognitive dysfunction". That is, it is not possible to evaluate possible dementia, but there is a risk of transitioning to suspicion of dementia when it is left unattended, using the HDS-R and MMSE.</summary>
    <dc:date>2017-06-29T15:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Timetable of Gait Cycle Events in Parkinson's Disease.</title>
    <link rel="alternate" href="http://hdl.handle.net/10564/3415" />
    <author>
      <name>Ueno, Satoshi</name>
    </author>
    <author>
      <name>Kiriyama, Takao</name>
    </author>
    <id>http://hdl.handle.net/10564/3415</id>
    <updated>2018-02-15T16:30:10Z</updated>
    <published>2017-06-29T15:00:00Z</published>
    <summary type="text">タイトル: Timetable of Gait Cycle Events in Parkinson's Disease.
著者: Ueno, Satoshi; Kiriyama, Takao
抄録: The study used an algorithmic method to measure fluctuations in the timetable of gait cycle events in patients with Parkinson's disease (PD). Subjects with severe PD (n=10; age 63.6 ± 10.1 years; Hoehn &amp; Yahr [H &amp; Y] disability score 3 or 4), mild PD (n=10; age 65.5 ± 4.3; H &amp; Y ≦ 2), and normal controls (n=10; age 65.1 ± 13.3) were studied. A camera was mounted on the trunk, and the subjects walked in a self-selected manner. Overhead images of the foot path were analyzed to geometrically describe motion in terms of displacement and velocity. The timing of three gait events, i.e.,¹⁾ feet adjacent,²⁾ maximum speed of swinging foot, and³⁾ the trunk climbing to its highest point in mid-stance, was determined for extracted steps during steady-state gait. In severe PD, 74.9 ± 21.7% of steps was timetabled so that the swinging leg and the stance-phase leg became side by side before the trunk rose to its highest point to achieve 'foot clearance'. This pattern was significantly less prevalent in mild PD and controls. An altered timetable of gait cycle events may provide quantitative indices of gait disability during steady-state walking in patients with PD.</summary>
    <dc:date>2017-06-29T15:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Feasibility and Efficacy of Definitive Radiotherapy with 66 Gy and Concurrent Carboplatin-Paclitaxel Chemotherapy for Stage III Non-Small Cell Lung Cancer.</title>
    <link rel="alternate" href="http://hdl.handle.net/10564/3414" />
    <author>
      <name>Inoue, Kazuya</name>
    </author>
    <author>
      <name>Hontsu, Shigeto</name>
    </author>
    <author>
      <name>Miura, Sachiko</name>
    </author>
    <author>
      <name>Asakawa, Isao</name>
    </author>
    <author>
      <name>Tamamoto, Tetsuro</name>
    </author>
    <author>
      <name>Yoshimine, Tadashi</name>
    </author>
    <author>
      <name>Kimura, Hiroshi</name>
    </author>
    <author>
      <name>Hasegawa, Masatoshi</name>
    </author>
    <id>http://hdl.handle.net/10564/3414</id>
    <updated>2018-02-15T16:30:11Z</updated>
    <published>2017-06-29T15:00:00Z</published>
    <summary type="text">タイトル: Feasibility and Efficacy of Definitive Radiotherapy with 66 Gy and Concurrent Carboplatin-Paclitaxel Chemotherapy for Stage III Non-Small Cell Lung Cancer.
著者: Inoue, Kazuya; Hontsu, Shigeto; Miura, Sachiko; Asakawa, Isao; Tamamoto, Tetsuro; Yoshimine, Tadashi; Kimura, Hiroshi; Hasegawa, Masatoshi
抄録: Purpose/Objectives : This study was conducted to assess the feasibility and efficacy of definitive radiotherapy (RT) with a total dose of 66 Gy and concurrent carboplatin-paclitaxel chemotherapy for patients (pts) with stage Ⅲ non-small celllung cancer. Materials/Methods : Between April 2007 and December 2013，99 pts with non-small cell lung cancer were treated using RT with concurrent carboplatin-paclitaxel chemotherapy in our hospital. Sixty-eight of them received RT with a total dose of 66 Gy. We analyzed 46 Stage Ⅲ pts who had been treated with RT using three-dimensional radiotherapy treatment planning. The prophylactic mediastinal lymph nodes were included in the clinical target volume for RT. The survival rate after the start of RT was estimated using the Kaplan-Meier method. We estimated the cumulative local failure and distant metastasis rates with the Fine-Gray method. Adverse events were evaluated according to the CTCAE (v.4.0). Results : The median age of the pts was 70.9 (52.8-78.7) years old (y.o.). The performance status (PS) of each pt was fairly good (ECOG PS 0: 25, PS 1: 20, PS 3:1), and their clinical stages (UICC 7th) were twenty-nine Ⅲ A and seventeen Ⅲ B. Diagnoses were pathologically confirmed in 32 pts. The median follow-up period was 35.7 (2.0-82.2) months among all pts, &#xD;
and 55.9 (40.1-82.2) months among survivors. The 3- and 5-year Kaplan-Meier overall survival rates were 52.2 and 34.0%，respectively, and the median survival time was 36.6 months. The 3- and 5-year Kaplan-Meier progression-free survival rates were 29.1 and 21.9%，respectively, and the median progression-free survival time was 9.9 months. The 5-year local failure rate was 37.6%, and the 5-year distant metastasis rate was 49.7%. Sixteen (34.8%) pts required steroid administration because of radiation pneumonitis (CTCAE Grade 2 or higher) and two of them died (Grade 5). No other severe non-hematologic toxicity (Grade 3 or higher) was observed. Conclusion : These results suggest that definitive RT with a total dose of 66 Gy and concurrent carboplatin-paclitaxel chemotherapy is feasible and may be promising for pts with Stage Ⅲ non-small cell lung cancer.</summary>
    <dc:date>2017-06-29T15:00:00Z</dc:date>
  </entry>
</feed>

